Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Method-specific Cortisol Responses to Short Synacthen Test
NCT00851942Phase 4Completed
- Sponsor
- Cardiff University
- Start
- Sep 2008
- Primary completion
- Jul 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tetracosactide hexaacetate in adrenal insufficiency (AI) and hypopituitarism, sponsored by Cardiff University. Primary endpoint: Method dependent cortisol cut offs for the normal response to Synacthen using the 5th percentile at 30 months. Started Sep 2008; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
adrenal insufficiency (AI)hypopituitarism
Beyond the preview
Go deeper on NCT00851942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851942.